by CILcare | Oct 12, 2021 | Non classé
Montpellier, October 13th, 2021: CILcare, the world leading CRO specialized in ear disorders, is pleased of nominating Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Aurore Marie will drive the support to production...
by CILcare | Jul 28, 2021 | Non classé
CILcare’s team is pleased to announce that the abstract co-written with Virbac, a top 10 animal health company, entitled “Ear inflammation and hearing measurements: taking advantage of preclinical tools to assess the Tolerance of otic products“ has been accepted for...
by CILcare | Jul 27, 2021 | Non classé
Do you want to know more about how to leverage pharma discovery engine to accelerate innovation in hearing health? How to develop repurposing and co-developing strategies to rapidly advance promising assets to the market? Find out in the presentation below given by...
by CILcare | Jul 9, 2021 | Non classé
Do you want to learn more on noise-induced hearing loss and ageing? Which strategies can you choose for a successful preclinical development? Find out by watching this presentation given by Dr Wahid Awad, CILcare’s Chief Business Officer, at BIO Korea 2021...
by CILcare | Jun 7, 2021 | Non classé
Montpellier & Seoul, June 8th, 2021: CILcare, the world’s leading CRO dedicated to ear disorders, and Knotus, a leading Korean non-clinical CRO, announced today that they have entered into a strategic partnership that aims at accelerating the development of...
